R. Sanders Williams

Insider Reports History

Entity
Individual
Location
Duke University School Of Medicine, Trent Drive, Durham, North Carolina
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for R. Sanders Williams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Sanders Williams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LABORATORY CORP OF AMERICA HOLDINGS Director Common Stock 8,120 $1.82 M $223.71 Feb 7, 2024 Direct
AMGEN INC Director Common Stock 6,240 $1.7 M $273.03 May 19, 2023 Direct
LABORATORY CORP OF AMERICA HOLDINGS Director Restricted Stock Unit 236 $52.8 K $223.71 Feb 7, 2024 Direct
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 29,532 Jun 9, 2023 Direct

Insider Reports Filed by R. Sanders Williams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LH LABORATORY CORP OF AMERICA HOLDINGS Feb 6, 2024 3 0 4 Feb 8, 2024 Director
TNYA Tenaya Therapeutics, Inc. Jun 9, 2023 1 0 4 Jun 12, 2023 Director
AMGN AMGEN INC May 19, 2023 1 0 4 May 23, 2023 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Feb 11, 2023 2 0 4 Feb 14, 2023 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Feb 7, 2023 1 0 4 Feb 9, 2023 Director
AMGN AMGEN INC Aug 22, 2022 1 -49,992 4 Aug 22, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jun 10, 2022 1 0 4 Jun 13, 2022 Director
AMGN AMGEN INC May 23, 2022 1 -150,000 4 May 23, 2022 Director
AMGN AMGEN INC May 17, 2022 1 0 4 May 19, 2022 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Mar 25, 2022 1 -156,145 4 Mar 29, 2022 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Feb 11, 2022 1 0 4/A Feb 15, 2022 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Feb 2, 2022 2 0 4 Feb 4, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 0 3 Jul 29, 2021 Director
AMGN AMGEN INC May 18, 2021 1 0 4 May 19, 2021 Director
AMGN AMGEN INC May 7, 2021 1 -62,945 4 May 10, 2021 Director